regulation

Group dismisses claims it failed in its role over Woodford fund

An adage of equity investing during a US presidential election cycle is 'avoid healthcare'.

Winning back consumer confidence months of scandal

Mirroring MiFID II compliance struggle

Experts warn of lengthy delays in investors recouping losses

Defunct fund's maintenance fees totalled over £184,000 a day

'Proud to be aligned with the event'

'Exact timescale' of complaints not yet provided

Investment complaints 2.1 per 1,000 products

'Form a basis for future work'